Injeksi Kortikosteroid Intratimpani pada Penanganan Penyakit Meniere

Oleh :

dr.Dhaniel Abdi Wicaksana, Sp.T.H.T.K.L., FICS

Injeksi kortikosteroid intratimpani dalam kontrol gejala vestibulocochlear akibat penyakit Meniere dianjurkan bila terapi farmakologi, seperti diuretik dan betahistin, gagal. Anjuran ini diberikan karena diduga memiliki efek samping sistemik yang lebih sedikit dibandingkan kortikosteroid sistemik. Penyakit Meniere merupakan kelainan telinga dalam yang ditandai dengan vertigo episodik, gangguan pendengaran sensorineural, dan tinnitus.

Mekanisme timbulnya penyakit Meniere hingga saat ini masih belum dipahami sepenuhnya, diduga terkait hidrops endolimfatik yang telah dihubungkan dengan mekanisme autoimun. Hal ini yang mendasari pertimbangan penggunaan steroid pada kasus penyakit Meniere yang gagal dengan terapi lini pertama.[1–3,12]

Kegunaan Steroid dalam Penyakit Meniere

(Konten ini khusus untuk dokter. Registrasi untuk baca selengkapnya)

Referensi

1. Beyea JA, Instrum RS, Agrawal SK, Parnes LS. Intratympanic dexamethasone in the treatment of meniere’s disease: a comparison of two techniques. Otology & Neurotology. 2017. 38(6):e173-e178. DOI: 10.1097/MAO.0000000000001437.
2. Molnar A, Maihoub S, Tamas L, Szirmai A. Effectiveness of intratymapnic dexamethasone for the treatment of vertigo attacks in patients with meniere’s disease compared with betahistine pharmacotherapy. Journal of International Medical Research. 2020; 49 (4): 1-7.
3. Saeed BMN, Tawalbeh M, Al-Omari AF. Intratympanic dexamethasone in meniere’s disease. Egyptian Journal of Ear, Nose Throat and Allied Sciences. 2016; 17: 63-9.
4. Basura GJ, Adams ME, Monfared A, Schwartz SR, Antonelli PJ, Burkard R, et al. Clinical practice guideline: meniere’s disease. American Academy of Otolaryngology-Head And Neck Surgery. 2020; 162 (2S): S1-S55.
5. Molnar A, Maihoub S, Tamas L, Szirmai A. Intratympanically administered steroid for progressive sensorineural hearing loss in meniere’s disease. Acta Oto-Laryngologica. 2019. 139(11):982-986. DOI: 10.1080/00016489.2019.1658898.
6. Oghan F, Erdim I, Celiker M, Topuz MF, Uluat A, Erdogan O, et al. Intratympanic steroid treatment in meniere disease. IntechOpen. 2017. DOI: http://dx.doi.org/10.5772/intechopen.69665.
7. Lee SY, Kim YS, Jeong B, Garandang M, Koo JW, Oh SH, et al. Intratympanic steroid versus gentamicin for treatment of refractory meniere’s disease: a meta-analysis. American Academy of Otolaryngology-Head And Neck Surgery. 2021. 42(3):103086. DOI: https://doi.org/10.1016/j.amjoto.2021.103086.
8. Senturk E., Tugrul S., Yildirim YS., Dogan R., Eren SB., Ozturan O. Are there any systemic effects of the intratympanic administration of dexamethasone. Bezmialem Science. 2018; 6 (3): 186-90.
9. Deenadayal DS., Vidyasagar D., Bommakanti V., Goel K., Naeem N. Role of intratympanic steroids in the management of meniere’s disease-a review of 151 cases. International Journal of Otolaryngology and Head & Neck Surgery. 2016; 5: 108-13.
10. Topcuoglu T., Kocyigit M., Bulut E., Ortekin SG., Kanter M. Yagiz R. The effects of experimental intratympanic steroid administration on organ of corti type 1 spiral ganglion. Int Arch Otorhinolaryngol. 2018; 22: 171-6.
11. de Cates C, Winters R. Intratympanic Steroid Injection. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK567708/
12. Nevoux J, Barbara M, Dornhoffer J, Gibson W, Kitahara T, Darrouzet V. International consensus (ICON) on treatment of Ménière's disease. Eur Ann Otorhinolaryngol Head Neck Dis. 2018 Feb;135(1S):S29-S32. doi: https://doi.org/10.1016/j.anorl.2017.12.006. Epub 2018 Jan 12. PMID: 29338942.
13. Schenck, Annejet A., et al. “Quality of Life after Intratympanic Steroid Injection for Ménière’s Disease.” Laryngoscope Investigative Otolaryngology, vol. 7, no. 3, 2022, pp. 825–831, https://doi.org/10.1002/lio2.798.